Please login to the form below

Not currently logged in

Precision medicine

This page shows the latest Precision medicine news and features for those working in and with pharma, biotech and healthcare.

FDA approves Novartis’ Pluvicto for prostate cancer

FDA approves Novartis’ Pluvicto for prostate cancer

Although the treatment landscape for mCRPC continues to evolve, there is a high unmet need for additional precision medicine treatment options to improve outcomes for these patients,” said Jamie Bearse, CEO

Latest news

More from news
Approximately 3 fully matching, plus 43 partially matching documents found.

Latest Intelligence

More from intelligence
Approximately 6 fully matching, plus 20 partially matching documents found.

Latest appointments

More from appointments
Approximately 0 fully matching, plus 8 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 27 fully matching, plus 17 partially matching documents found.

Subscribe to our email news alerts

Featured jobs


Add my company

Hamell is a full-service agency with a clear focus on delivering evidence-based, sustained behaviour change. So, whether you are looking...

Latest intelligence

Our Top 5 Pharma Picks From Cannes Lions
Here are five of Art's top five pharma and healthcare picks from Cannes Lions 2022....
The Evolving Role of the Sales Rep
The COVID-19 pandemic sparked an evolution in physician engagement. Jill Padgett, EdD, Head of Training, explores what this means for the sales force and shares her advice for succeeding in...
Measure your omnichannel maturity with our new tool
Try our Omnichannel Maturity Tool to gain tangible advice and an instant analysis of your omnichannel readiness....